GUAIFENESIN 400MG CAPLETS
- Product NDC
- 77333-360
- 11-digit product format
- 773330360
- Labeler code
- 77333
- Product ID
- 77333-360_48032e44-d1b5-ea4d-e063-6394a90aba26
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- GUAIFENESIN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Gendose Pharmaceuticals, LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-09-02
- Substance
- GUAIFENESIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 77333-360 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 1332a3947898… | d4bfe170f9cd… | ||
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 77333-360 | 77333-360-10 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GUAIFENESIN 400MG CAPLETS
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 400 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 359601 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e7b82ec7-ef23-50c1-e053-2a95a90a662f | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-05-02 | GENDOSE - GUAIFENESIN 400 mg CAPLETS (77333-360) |
| 2024-05-02 | GENDOSE - GUAIFENESIN 400 mg CAPLETS (77333-360) |
| 2024-01-30 | GENDOSE - GUAIFENESIN 400 mg CAPLETS (77333-360) |
| 2024-01-30 | GENDOSE - GUAIFENESIN 400 mg CAPLETS (77333-360) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 77333-360-10 | GUAIFENESIN 400MG CAPLETS | 100 in 1 BOX | TABLET | 100 | 7 | |
| 77333-360-25 | GUAIFENESIN 400MG CAPLETS | 1 in 1 BLISTER PACK | TABLET | 1 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 77333-360-10 | EA - Each | 77333-360 | 59e4bbd3-6be1-4beb-b0d0-7887c8855797 | 1 | 2022-10-06 |
| 77333-360-25 | EA - Each | 77333-360 | 3f337a09-e952-4310-a7aa-c0fc1effdaf0 | 1 | 2022-10-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pediacare Childrens Cough and Congestion Grape | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH | 9576723b-748c-45e7-bc0d-cc109b9f6735 | 2024-12-30 | Warnings | M012 |
| Cold and Flu Nighttime Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Lil' Drug Store Products, Inc. | ef6836fa-d104-d7b3-e053-2a95a90af2b8 | 2024-12-30 | Warnings | M012 |
| Circle K Congestion Relief | OXYMETAZOLINE HYDROCHLORIDE | Lil' Drug Store Products, Inc | 7e02fe57-f42f-4d3c-9002-4c4c0b1fafd6 | 2024-12-30 | Warnings | M012 |
| SDA Laboratories Tussin | GUAIFENESIN | SDA Laboratories, Inc. | 2a444cc8-96be-9432-e063-6394a90a1b63 | 2024-12-27 | Warnings | M012 |
| SDA Laboratories Tussin DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | SDA Laboratories, Inc. | 2a445f31-818d-11b1-e063-6294a90a8cb1 | 2024-12-27 | Warnings | M012 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Richmond Pharmaceuticals Inc. | f184b2aa-91a4-44f9-b688-d4e318181984 | 2024-12-26 | Warnings | M012 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Richmond Pharmaceuticals, Inc. | 2792032a-ff0f-4d5f-a8e3-b8b8c54f4e99 | 2024-12-26 | Warnings | M012 |
| OXYMETAZOLINE HYDROCHLORIDE | OXYMETAZOLINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION INC. | c7b1f980-9b0d-4f63-a70d-fd366658f863 | 2024-12-26 | Warnings | M012 |
| OXYMETAZOLINE HYDROCHLORIDE | OXYMETAZOLINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION INC. | 2ee2b332-9b85-45a6-b242-3f0ebfbd08a6 | 2024-12-26 | Warnings | M012 |
| OXYMETAZOLINE HYDROCHLORIDE | OXYMETAZOLINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION INC | aebc7cf8-aaf7-4746-89f5-a64d0be1641e | 2024-12-26 | Warnings | M012 |
| Foster and Thrive Chest Congestion Relief | GUAIFENESIN | Strategic Sourcing Services LLC | a1661a66-5e8c-4144-9c82-cbbcc75fb222 | 2024-12-23 | Warnings | M012 |
| Geri Dryl | DIPHENHYDRAMINE HCL | GERI-CARE PHARMACEUTICALS, CORP | 34d36146-6827-4800-8483-c0edb8f4cc28 | 2024-12-23 | Warnings | M012 |
| Guaiasorb DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Geri-Care Pharmaceuticals, Corp | 6299e352-116e-43f2-b40f-c704a7bd5d61 | 2024-12-23 | Warnings | M012 |
| Equaline Chest Congestion Relief | GUAIFENESIN | United Natural Foods, Inc. dba UNFI | ad9fde8b-10cd-4778-917d-1ed6b67e5ab1 | 2024-12-23 | Warnings | M012 |
| Equaline Chest Congestion Relief DM DM | DEXTROMETHORPHAN HYDROBROMIDE / GUAIFENESIN | United Natural Foods, Inc. dba UNFI | a40f5893-eb96-4e0e-b965-d78293c48dc9 | 2024-12-23 | Warnings | M012 |
| Tukol X-Pecto Miel Multi Symptom Cold | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Genomma Lab USA, Inc. | b9d32964-5bd7-44b0-be98-827d5310ed4f | 2024-12-20 | Warnings | M012 |
| Halls Honey Vanilla | MENTHOL | Mondelez Global LLC | 8e94a1b8-8915-4595-b097-8a0a319d54aa | 2024-12-20 | Warnings | M012 |
| Halls Sugar Free Mentho-Lyptus | MENTHOL | Mondelez Global LLC | 96046858-c57b-426e-8279-91b35e05bcdb | 2024-12-20 | Warnings | M012 |
| Vapor Inhaler levmetamfetamine nasal decongestant, Best Choice | LEVMETAMFETAMINE | Valu Merchandisers Company | 3f1c086c-bc22-4abb-9921-565a13f30c20 | 2024-12-20 | Warnings | M012 |
| Vapor Inhaler | LEVMETAMFETAMINE NASAL DECONGESTANT | Walgreens | 77924474-ccc7-497b-9168-91490bcfadfc | 2024-12-20 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 359601 | guaiFENesin 400 MG Oral Tablet | PSN | e7b82ec7-ef23-50c1-e053-2a95a90a662f | 7 |
| 359601 | guaifenesin 400 MG Oral Tablet | SCD | e7b82ec7-ef23-50c1-e053-2a95a90a662f | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 77333-360-10 | 77333036010 | 100 BLISTER PACK in 1 BOX (77333-360-10) / 1 TABLET in 1 BLISTER PACK (77333-360-25) | 100 blister pack | 2022-09-02 | 0000-00-00 | No | No | Current |
| 77333-360-25 | 77333036025 | 1 in 1 BLISTER PACK | Historical |